Highlighting Innovation: A Video Breakdown of AST’s New Fill-Finish Isolator

AST aseptic manufacturing fill-finish isolator unit with director of engineering spencer bolte
Share our post

AST’s Director of Engineering Spencer Bolte walks through some of the key design considerations on AST’s new isolator including operator-centered solutions and a groundbreaking new decontamination technology for complete 60-minute cycle times, including aeration.

The newly unveiled AST isolator and the latest generation GENiSYS C are two of AST’s intuitive, compact solutions for high-value liquid pharmaceuticals requiring maximum yield and complete product stewardship. Designed with superior flexibility and ultimate efficiency, both these products are built to meet the multi-modal requirements of many of today’s parenteral drug manufacturers looking to keep their operational footprint small and their drug development process agile.

The GENiSYS C combines robust automation with easy-to-operate processes and recipe-driven production, utilizing features traditionally found in large-scale filling lines to process a variety of ready-to-use and custom containers. 

The AST isolator is next-generation barrier technology leveraging innovative automation and a user-friendly design for a best-in-class isolator solution that integrates exclusively with AST’s aseptic processing systems. 

Learn how AST can provide your organization with 100 percent integrated isolated fill-finish technology – reach out to our experts today.